Toni K. Choueiri, MD, on the Effects of Cancer Treatments on Patients Infected With COVID-19
AACR Virtual Meeting: COVID-19 and Cancer 2021
Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discusses the challenges of delivering optimal cancer treatments in the face of the coronavirus pandemic. Focusing on systemic therapies, he reviews prognostic factors in people with cancer and COVID-19 (Symposium 9).
The ASCO Post Staff
David Fajgenbaum, MD, MBA, of the University of Pennsylvania, talks about his research efforts to find an already-approved drug that could treat his orphan disease—multicentr...
The ASCO Post Staff
Giuseppe Curigliano, MD, PhD, of the University of Milan and Istituto Europeo Oncologico, talks about designing public health measures focused on COVID-19 morbidity and morta...
The ASCO Post Staff
Antoni Ribas, MD, PhD, of the University of California, Los Angeles and Jonsson Comprehensive Cancer Center, and President of the American Association for Cancer Research, ta...
